Last reviewed · How we verify
Intramuscular mode of administration — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Intramuscular mode of administration (Intramuscular mode of administration) — Objectif Recherche Vaccins SIDA.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intramuscular mode of administration TARGET | Intramuscular mode of administration | Objectif Recherche Vaccins SIDA | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intramuscular mode of administration CI watch — RSS
- Intramuscular mode of administration CI watch — Atom
- Intramuscular mode of administration CI watch — JSON
- Intramuscular mode of administration alone — RSS
Cite this brief
Drug Landscape (2026). Intramuscular mode of administration — Competitive Intelligence Brief. https://druglandscape.com/ci/intramuscular-mode-of-administration. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab